# APTX

## Overview
The APTX gene encodes the aprataxin protein, a critical component in the DNA repair machinery of human cells. Aprataxin is classified as a hydrolase, specifically involved in resolving abortive DNA ligation intermediates by removing adenosine monophosphate (AMP) groups from the 5'-end of DNA, thereby maintaining genomic stability (Imamura2023APTX; Daley2010Genetic). The protein is characterized by several conserved domains, including a histidine triad (HIT) domain, a zinc finger (Znf) domain, and an N-terminal forkhead-associated (FHA) domain, which facilitate its interactions with DNA and other repair proteins (Tumbale2011Structure; Schellenberg2015Molecular). Aprataxin operates in both the nucleus and mitochondria, playing a vital role in single-strand break repair (SSBR) and base excision repair (BER) pathways, as well as maintaining mitochondrial function (Gueven2004Aprataxin; Zheng2019Diminished). Mutations in the APTX gene are linked to ataxia with oculomotor apraxia type 1 (AOA1), a neurodegenerative disorder, underscoring the clinical significance of this gene in human health (Imamura2023APTX; Ababneh2020Identification).

## Structure
The APTX (aprataxin) protein is characterized by several conserved domains that contribute to its function in DNA repair. It includes a histidine triad (HIT) domain and a zinc finger (Znf) domain, which together form the core structure of the protein. The HIT domain is part of a superfamily known for nucleoside hydrolase and transferase activities and consists of a central five-stranded anti-parallel β-sheet surrounded by helical elements (Tumbale2011Structure; Schellenberg2015Molecular). The Znf domain, which is structurally related to the classical C2H2 Zn-finger fold, includes a C2HE Zn-binding core that facilitates sequence-independent DNA binding (Tumbale2011Structure).

The APTX protein also contains an N-terminal forkhead-associated (FHA) domain, which aids in phosphorylation-regulated interactions with other DNA repair proteins (Schellenberg2015Molecular). The protein's structure includes a helical wedge that senses DNA ends or nicks, contributing to its role in DNA repair (Tumbale2011Structure). The HIT and Znf domains form an electropositive DNA binding platform, with AMP binding in a hydrophobic pocket (Tumbale2011Structure).

APTX operates through a two-step catalytic mechanism involving a covalent AMP-enzyme intermediate, and its structure is crucial for recognizing and processing adenylated nucleic acid termini (Schellenberg2015Molecular). The protein's unique structure differentiates it as a hydrolase of asymmetric polynucleotide adenylates (Schellenberg2015Molecular).

## Function
The APTX gene encodes the aprataxin protein, which plays a crucial role in DNA repair processes in human cells. Aprataxin is primarily involved in resolving abortive DNA ligation intermediates by removing adenosine monophosphate (AMP) groups from the 5'-end of DNA. This activity is essential for maintaining genomic stability, as it facilitates proper DNA ligation and prevents the accumulation of abortive ligation products that could lead to DNA damage (Imamura2023APTX; Daley2010Genetic).

Aprataxin is active in both the nucleus and mitochondria, with evidence suggesting a more critical role in mitochondrial DNA repair. In the nucleus, it interacts with key DNA repair proteins such as XRCC1 and PARP-1, indicating its involvement in single-strand break repair (SSBR) and base excision repair (BER) pathways (Gueven2004Aprataxin; Zheng2019Diminished). In mitochondria, aprataxin is essential for maintaining mitochondrial function and homeostasis, influencing mitochondrial membrane potential, reactive oxygen species production, and oxidative phosphorylation system function (Zheng2019Diminished).

The protein's activity is crucial for preventing neurodegenerative disorders, as mutations in the APTX gene can lead to conditions such as ataxia oculomotor apraxia 1 (AOA1) (Imamura2023APTX).

## Clinical Significance
Mutations in the APTX gene, which encodes the aprataxin protein, are primarily associated with ataxia with oculomotor apraxia type 1 (AOA1), a neurodegenerative disorder. AOA1 is characterized by early-onset cerebellar ataxia, oculomotor apraxia, cerebellar atrophy, severe peripheral neuropathy, distal muscle wasting and weakness, and chorea (Aguillon2022Ataxia; Ababneh2020Identification). The p.W279* mutation in APTX is particularly noted for its prevalence and association with early-onset symptoms (Renaud2018Clinical). 

APTX mutations lead to protein destabilization, affecting its ability to perform DNA repair functions, which results in increased oxidative DNA damage and sensitivity to DNA-damaging agents (Tumbale2018Mechanism). These mutations can also cause mitochondrial dysfunction, independent of their role in DNA repair, contributing to the pathogenesis of AOA1 (GarciaDiaz2015Lack). 

The clinical presentation of AOA1 can vary, with some patients exhibiting additional symptoms such as hypoalbuminemia, hypercholesterolemia, and cognitive impairment (GarciaDiaz2015Lack; Albaradie2022Ataxia). The variability in phenotype may be influenced by the specific type and location of APTX mutations (Yoon2018Nonsyndromic).

## Interactions
Aprataxin (APTX) is involved in several critical interactions with proteins and nucleic acids, playing a significant role in DNA repair processes. APTX interacts with the X-ray repair cross-complementing group 1 (XRCC1) protein, a key component in single-strand DNA break repair (SSBR). This interaction is mediated by the forkhead-associated (FHA) domain of APTX and the C-terminal region of XRCC1, specifically involving the N-terminal 20 amino acids of APTX and residues 492-574 of XRCC1 (Date2004The).

APTX also forms complexes with poly (ADP-ribose) polymerase-1 (PARP-1), suggesting a collaborative role in SSBR. The interaction with PARP-1 was confirmed through co-immunoprecipitation assays, although it appears to be weak or condition-dependent (Date2004The).

In terms of nucleic acid interactions, APTX is involved in resolving adenylated RNA-DNA junctions, which is crucial for maintaining genome integrity. The protein's HIT and zinc finger (Znf) domains form a scaffold that binds to DNA, facilitating the repair of 5′-adenylated DNA substrates. This interaction involves a sequence-independent mechanism, primarily through sugar-phosphate contacts in the DNA minor groove (Tumbale2013Aprataxin; Tumbale2011Structure).


## References


[1. (Renaud2018Clinical) Mathilde Renaud, Maria-Céu Moreira, Bondo Ben Monga, Diana Rodriguez, Rabab Debs, Perrine Charles, Malika Chaouch, Farida Ferrat, Chloé Laurencin, Laurent Vercueil, Martial Mallaret, Abderrahim M’Zahem, Lamia Ali Pacha, Meriem Tazir, Caroline Tilikete, Elisabeth Ollagnon, François Ochsner, Thierry Kuntzer, Hans H. Jung, Jean-Marie Beis, Jean-Claude Netter, Atbin Djamshidian, Mattew Bower, Armand Bottani, Richard Walsh, Sinead Murphy, Thomas Reiley, Éric Bieth, Filip Roelens, Bwee Tien Poll-The, Charles Marques Lourenço, Laura Bannach Jardim, Rachel Straussberg, Pierre Landrieu, Emmanuel Roze, Stéphane Thobois, Jean Pouget, Claire Guissart, Cyril Goizet, Alexandra Dürr, Christine Tranchant, Michel Koenig, and Mathieu Anheim. Clinical, biomarker, and molecular delineations and genotype-phenotype correlations of ataxia with oculomotor apraxia type 1. JAMA Neurology, 75(4):495, April 2018. URL: http://dx.doi.org/10.1001/jamaneurol.2017.4373, doi:10.1001/jamaneurol.2017.4373. This article has 27 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1001/jamaneurol.2017.4373)

[2. (Yoon2018Nonsyndromic) Grace Yoon and Keith W. Caldecott. Nonsyndromic cerebellar ataxias associated with disorders of DNA single-strand break repair, pages 105–115. Elsevier, 2018. URL: http://dx.doi.org/10.1016/b978-0-444-64189-2.00007-x, doi:10.1016/b978-0-444-64189-2.00007-x. This article has 37 citations.](https://doi.org/10.1016/b978-0-444-64189-2.00007-x)

[3. (Tumbale2018Mechanism) Percy Tumbale, Matthew J Schellenberg, Geoffrey A Mueller, Emma Fairweather, Mandy Watson, Jessica N Little, Juno Krahn, Ian Waddell, Robert E London, and R Scott Williams. Mechanism of <scp>aptx</scp> nicked <scp>dna</scp> sensing and pleiotropic inactivation in neurodegenerative disease. The EMBO Journal, June 2018. URL: http://dx.doi.org/10.15252/embj.201798875, doi:10.15252/embj.201798875. This article has 12 citations.](https://doi.org/10.15252/embj.201798875)

[4. (Zheng2019Diminished) Jin Zheng, Deborah L Croteau, Vilhelm A Bohr, and Mansour Akbari. Diminished opa1 expression and impaired mitochondrial morphology and homeostasis in aprataxin-deficient cells. Nucleic Acids Research, 47(8):4086–4110, February 2019. URL: http://dx.doi.org/10.1093/nar/gkz083, doi:10.1093/nar/gkz083. This article has 24 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkz083)

[5. (GarciaDiaz2015Lack) Beatriz Garcia-Diaz, Emanuele Barca, Andrea Balreira, Luis C. Lopez, Saba Tadesse, Sindhu Krishna, Ali Naini, Caterina Mariotti, Barbara Castellotti, and Catarina M. Quinzii. Lack of aprataxin impairs mitochondrial functions via downregulation of the ape1/nrf1/nrf2 pathway. Human Molecular Genetics, 24(16):4516–4529, May 2015. URL: http://dx.doi.org/10.1093/hmg/ddv183, doi:10.1093/hmg/ddv183. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddv183)

[6. (Tumbale2013Aprataxin) Percy Tumbale, Jessica S. Williams, Matthew J. Schellenberg, Thomas A. Kunkel, and R. Scott Williams. Aprataxin resolves adenylated rna–dna junctions to maintain genome integrity. Nature, 506(7486):111–115, December 2013. URL: http://dx.doi.org/10.1038/nature12824, doi:10.1038/nature12824. This article has 90 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature12824)

[7. (Imamura2023APTX) Rikiya Imamura, Mizuki Saito, Mikio Shimada, Junya Kobayashi, Masamichi Ishiai, and Yoshihisa Matsumoto. Aptx acts in dna double-strand break repair in a manner distinct from xrcc4. Journal of Radiation Research, 64(3):485–495, March 2023. URL: http://dx.doi.org/10.1093/jrr/rrad007, doi:10.1093/jrr/rrad007. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/jrr/rrad007)

[8. (Schellenberg2015Molecular) Matthew J. Schellenberg, Percy P. Tumbale, and R. Scott Williams. Molecular underpinnings of aprataxin rna/dna deadenylase function and dysfunction in neurological disease. Progress in Biophysics and Molecular Biology, 117(2–3):157–165, March 2015. URL: http://dx.doi.org/10.1016/j.pbiomolbio.2015.01.007, doi:10.1016/j.pbiomolbio.2015.01.007. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.pbiomolbio.2015.01.007)

[9. (Gueven2004Aprataxin) N. Gueven. Aprataxin, a novel protein that protects against genotoxic stress. Human Molecular Genetics, 13(10):1081–1093, March 2004. URL: http://dx.doi.org/10.1093/hmg/ddh122, doi:10.1093/hmg/ddh122. This article has 136 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddh122)

[10. (Albaradie2022Ataxia) Raidah Albaradie, Alanoud Alharbi, Gada Alsaffar, Bayader Alhamad, and Shahid Bashir. Ataxia with oculomotor apraxia type 1 associated with mutation in the aptx gene: a case study and literature review. Experimental and Therapeutic Medicine, October 2022. URL: http://dx.doi.org/10.3892/etm.2022.11645, doi:10.3892/etm.2022.11645. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/etm.2022.11645)

[11. (Date2004The) Hidetoshi Date, Shuichi Igarashi, Yasuteru Sano, Toshiaki Takahashi, Tetsuya Takahashi, Hiroki Takano, Shoji Tsuji, Masatoyo Nishizawa, and Osamu Onodera. The fha domain of aprataxin interacts with the c-terminal region of xrcc1. Biochemical and Biophysical Research Communications, 325(4):1279–1285, December 2004. URL: http://dx.doi.org/10.1016/j.bbrc.2004.10.162, doi:10.1016/j.bbrc.2004.10.162. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2004.10.162)

[12. (Aguillon2022Ataxia) David Aguillon, Daniel Vasquez, Lucia Madrigal, Sonia Moreno, Dora Hernández, Mario Isaza-Ruget, Juan Javier Lopez, Iván Landires, Virginia Nuñez-Samudio, Carlos M. Restrepo, Oscar M. Vidal, Jorge I. Vélez, Mauricio Arcos-Holzinger, Francisco Lopera, and Mauricio Arcos-Burgos. Ataxia with ocular apraxia type 1 (aoa1) (aptx, w279* mutation): neurological, neuropsychological, and molecular outlining of a heterogenous phenotype in four colombian siblings. Molecular Neurobiology, 59(6):3845–3858, April 2022. URL: http://dx.doi.org/10.1007/s12035-022-02821-7, doi:10.1007/s12035-022-02821-7. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-022-02821-7)

[13. (Daley2010Genetic) James M. Daley, Thomas E. Wilson, and Dindial Ramotar. Genetic interactions between hnt3/aprataxin and rad27/fen1 suggest parallel pathways for 5′ end processing during base excision repair. DNA Repair, 9(6):690–699, June 2010. URL: http://dx.doi.org/10.1016/j.dnarep.2010.03.006, doi:10.1016/j.dnarep.2010.03.006. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.dnarep.2010.03.006)

[14. (Tumbale2011Structure) Percy Tumbale, C Denise Appel, Rolf Kraehenbuehl, Patrick D Robertson, Jessica S Williams, Joe Krahn, Ivan Ahel, and R Scott Williams. Structure of an aprataxin–dna complex with insights into aoa1 neurodegenerative disease. Nature Structural &amp; Molecular Biology, 18(11):1189–1195, October 2011. URL: http://dx.doi.org/10.1038/nsmb.2146, doi:10.1038/nsmb.2146. This article has 34 citations.](https://doi.org/10.1038/nsmb.2146)

[15. (Ababneh2020Identification) Nidaa A. Ababneh, Dema Ali, Ban Al-Kurdi, Malik Sallam, Abdulla M. Alzibdeh, Bareqa Salah, Abdee T. Ryalat, Belal Azab, Basil Sharrack, and Abdalla Awidi. Identification of aptx disease-causing mutation in two unrelated jordanian families with cerebellar ataxia and sensitivity to dna damaging agents. PLOS ONE, 15(8):e0236808, August 2020. URL: http://dx.doi.org/10.1371/journal.pone.0236808, doi:10.1371/journal.pone.0236808. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0236808)